Overview
What is Molecular Biology Consortium Inc?
Molecular Biology Consortium Inc, located in Naperville, Illinois, is a nonprofit organization dedicated to scientific research and teaching. With a focus on improving public health and welfare, they utilize an X-ray beamline for their studies. Notably, their efforts aided in the development of Sotrovimab, an antibody therapy that neutralizes SARS-COV-2 strains and other coronaviruses. Dr. Jay Nix, the beamline director, performed X-ray crystallography on survivor-derived antibodies, contributing to detailed structural maps of how these antibodies bind to the SARS-COV-2 spike protein. The findings were instrumental in creating Sotrovimab, which was developed by GlaxoSmithKline and Vir Biotechnology. The consortium employs a total of 3 individuals in its mission to advance scientific knowledge.
Official website here: www.mbc-als.org
Is Molecular Biology Consortium Inc legitimate?
Molecular Biology Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Molecular Biology Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $11,250
Professional Fundraising Fees: $0
Other Salaries and Wages: $254,457
For more financial information, click here
Official website here: www.mbc-als.org
What is the mission statement of Molecular Biology Consortium Inc?
The Molecular Biology Consortium Inc is dedicated to conducting scientific research and teaching with the primary objective of enhancing public health and welfare. Their activities primarily involve utilizing an X-ray beamline for research purposes. Notably, they played a role in the development of an antibody therapy named Sotrovimab, which aids in neutralizing various SARS-COV-2 strains and other coronaviruses. This was achieved with the assistance of structural biologist Dr. Jay Nix's X-ray crystallography findings on survivor-derived antibodies. These findings, along with other crystallography and microscopy results, contributed to generating detailed structural maps of how these antibodies bind to the SARS-COV-2 spike protein. GlaxoSmithKline and Vir Biotechnology subsequently utilized these structural maps to develop Sotrovimab.
Official website here: www.mbc-als.org
Who is the CEO of Molecular Biology Consortium Inc?
Philip Matsumura is the Director of Molecular Biology Consortium Inc.
Official website here: www.mbc-als.org
What is the revenue of Molecular Biology Consortium Inc?
Molecular Biology Consortium Inc's revenue in 2022 was $446,784.
Official website here: www.mbc-als.org
Who are the executives of Molecular Biology Consortium Inc and what are their salaries?
The average compensation at Molecular Biology Consortium Inc during 2022 was $88,569. There are 3 employees and 8 volunteers at Molecular Biology Consortium Inc.
Here are 9 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $11,250
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $208,365
- Related: $0
- Other: $43,894
Official website here: www.mbc-als.org
Where can I find the form 990 for Molecular Biology Consortium Inc?
Molecular Biology Consortium Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.mbc-als.org
Learn more at the official website: www.mbc-als.org
Mission Statement of Molecular Biology Consortium Inc
Molecular Biology Consortium Inc is dedicated to advancing scientific research and education with a focus on improving public health and welfare. One of their significant contributions in this regard is the development of an antibody therapy called Sotrovimab. This therapy, which was aided by the consortium's structural biologist, Dr. Jay Nix, helps neutralize various SARS-CoV-2 strains and other coronaviruses. Dr. Nix, as the beamline director of Molecular Biology Consortium, utilized X-ray crystallography on samples of survivor-derived antibodies. His findings, combined with other crystallography and microscopy results, contributed to the generation of detailed structural maps illustrating how these antibodies bind to the SARS-CoV-2 spike protein. GlaxoSmithKline and Vir Biotechnology then utilized these structural maps to develop Sotrovimab. By engaging in such groundbreaking research, Molecular Biology Consortium Inc plays a crucial role in combating infectious diseases and enhancing public health.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Molecular Biology Consortium Inc has significantly advanced the field of scientific research and public health through its pioneering work in X-ray crystallography. By utilizing its beamline facilities, the consortium has facilitated critical studies that led to the development of antibody therapies, such as Sotrovimab, aimed at neutralizing SARS-CoV-2 and other coronaviruses.
Dr. Jay Nix, the beamline director, played a pivotal role in this process by generating detailed structural maps that illustrate how survivor-derived antibodies interact with the SARS-CoV-2 spike protein. These insights were instrumental for pharmaceutical companies like GlaxoSmithKline and Vir Biotechnology in creating effective treatments against COVID-19.
Through its focus on scientific research and education, Molecular Biology Consortium Inc directly contributes to improving public health and welfare, making significant strides in the battle against viral diseases. Their work not only supports current biomedical advancements but also fosters a deeper understanding of viral mechanisms, ultimately benefiting society as a whole.
This information is meant to be a general summary of Molecular Biology Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $369
- Program Service Revenue: $287,200
- Gross Receipts: $446,784
Assets and Liabilities:
- Total Assets: $979,055
- Total Liabilities: $66,141
- Net Assets: $912,914
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
MEMBER USAGE FEES
Revenue
$250,000
NON-MEMBER USAGE FEES
Revenue
$37,200
Organization Details
Founding Year
1999
Phone
(708) 776-0350Principal Officer
Philip Matsumura
Main Address
5 SOUTH WASHINGTON STREET 626, NAPERVILLE, IL, 60566
Website
www.mbc-als.orgNTEE Category
Code: M032 - Public safety
If you are a representative of Molecular Biology Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.